The disproportionate case-fatality ratio of COVID-19 between countries with the highest vaccination rates and the rest of the world

被引:5
作者
Haider, Najmul [1 ,12 ]
Hasan, Mohammad Nayeem [2 ]
Guitian, Javier
Khan, Rumi A. [3 ]
Mccoy, David [4 ]
Ntoumi, Francine [5 ,6 ]
Dar, Osman [7 ]
Ansumana, Rashid [8 ]
Uddin, Md. Jamal [2 ,9 ,12 ]
Zumla, Alimuddin [10 ,11 ]
Kock, Richard A.
机构
[1] Univ London, Royal Vet Coll, Hatfield, England
[2] Keele Univ, Sch Life Sci, Keele ST5 5BG, England
[3] Shahjalal Univ Sci & Technol, Dept Stat, Sylhet, Bangladesh
[4] Univ Texas Austin, Div Pulm Crit Care Med, Dell Med Sch, Austin, TX USA
[5] Queen Mary Univ London, Inst Populat Hlth Sci, Barts & London Sch Med & Dent, London, England
[6] Congolese Fdn Med Res, Brazzaville, Rep Congo
[7] Univ Tubingen, Inst Trop Med, Tubingen, Germany
[8] Royal Inst Int Affairs, Chatham House Ctr Global Hlth Secur, London, England
[9] Njala Univ, Sch Community Hlth Sci, Bo, Sierra Leone
[10] Daffodil Int Univ, Dept Gen Educ Dev, Dhaka, Bangladesh
[11] UCL, Div Infect & Immun, Ctr Clin Microbiol, London, England
[12] Univ Coll London Hosp, NIHR, BRC, London, England
来源
IJID REGIONS | 2023年 / 6卷
关键词
COVID-19; SARS-CoV-2; Case-fatality ratio; Vaccine equity; Variants of concern; Vaccine roll out;
D O I
10.1016/j.ijregi.2023.01.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The global reported cumulative case-fatality ratios (rCFRs) and excess mortality rates of the 20 countries with the highest coronavirus disease 2019 (COVID-19) vaccination rates, the rest of the world and SubSaharan Africa (SSA) were compared before and after the commencement of vaccination programmes.Methods: A time series model was used to understand the trend of rCFR over time, and a generalized linear mixed model was used to understand the effect of vaccination on rCFR.Results: By 31 December 2022, an average of 260.3 doses of COVID-19 vaccine per 100 population had been administered in the top 20 vaccinated countries, compared with 152.1 doses in the rest of the world and 51.2 doses in SSA. The mean rCFR of COVID-19 had decreased by 69.0% in the top 20 vaccinated countries, 26.5% in the rest of the world and 7.6% in SSA. Excess mortality had decreased by 48.7% in the top 20 vaccinated countries, compared with 62.5% in the rest of the world and 60.7% in SSA. In a generalized linear mixed model, the reported number of vaccine doses administered (/100 population) (odds ratio 0.64) was associated with a steeper reduction in COVID-19 rCFR.Conclusions: Vaccine equity and faster roll-out across the world is critically important in reducing COVID-19 transmission and CFR.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 48 条
  • [1] Estimation of novel coronavirus (COVID-19) reproduction number and case fatality rate: A systematic review and meta-analysis
    Ahammed, Tanvir
    Anjum, Aniqua
    Rahman, Mohammad Meshbahur
    Haider, Najmul
    Kock, Richard
    Uddin, Md Jamal
    [J]. HEALTH SCIENCE REPORTS, 2021, 4 (02)
  • [2] Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
    Altarawneh, Heba N.
    Chemaitelly, Hiam
    Hasan, Mohammad R.
    Ayoub, Houssein H.
    Qassim, Suelen
    AlMukdad, Sawsan
    Coyle, Peter
    Yassine, Hadi M.
    Al-Khatib, Hebah A.
    Benslimane, Fatiha M.
    Al-Kanaani, Zaina
    Al-Kuwari, Einas
    Jeremijenko, Andrew
    Kaleeckal, Anvar H.
    Latif, Ali N.
    Shaik, Riyazuddin M.
    Abdul-Rahim, Hanan F.
    Nasrallah, Gheyath K.
    Al-Kuwari, Mohamed G.
    Butt, Adeel A.
    Al-Romaihi, Hamad E.
    Al-Thani, Mohamed H.
    Al-Khal, Abdullatif
    Bertollini, Roberto
    Tang, Patrick
    Abu-Raddad, Laith J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (13) : 1288 - 1290
  • [3] [Anonymous], 2020, BBC NEWS
  • [4] Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
    Bernal, Jamie Lopez
    Andrews, Nick
    Gower, Charlotte
    Robertson, Chris
    Stowe, Julia
    Tessier, Elise
    Simmons, Ruth
    Cottrell, Simon
    Roberts, Richard
    O'Doherty, Mark
    Brown, Kevin
    Cameron, Claire
    Stockton, Diane
    McMenamin, Jim
    Ramsay, Mary
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [5] Checchi F, 2005, Interpreting and using mortality data in humanitarian emergencies: a primer for non-epidemiologists
  • [6] BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
    Dagan, Noa
    Barda, Noam
    Kepten, Eldad
    Miron, Oren
    Perchik, Shay
    Katz, Mark A.
    Hernan, Miguel A.
    Lipsitch, Marc
    Reis, Ben
    Balicer, Ran D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (15) : 1412 - 1423
  • [7] de Dieu Longo J, Lancet
  • [8] Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI [10.3760/cma.j.issn.0254-6450.2020.02.003, 10.46234/ccdcw2020.032]
  • [9] Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
    Fu, Leiwen
    Wang, Bingyi
    Yuan, Tanwei
    Chen, Xiaoting
    Ao, Yunlong
    Fitzpatrick, Thomas
    Li, Peiyang
    Zhou, Yiguo
    Lin, Yi-fan
    Duan, Qibin
    Luo, Ganfeng
    Fan, Song
    Lu, Yong
    Feng, Anping
    Zhan, Yuewei
    Liang, Bowen
    Cai, Weiping
    Zhang, Lin
    Du, Xiangjun
    Li, Linghua
    Shu, Yuelong
    Zou, Huachun
    [J]. JOURNAL OF INFECTION, 2020, 80 (06) : 656 - 665
  • [10] Giattino C, 2020, Excess mortality during the Coronavirus pandemic (COVID-19): Our World in Data